Cited by 843D Printing in Biomedical ResearchCancer Cells and MetastasisAngiogenesis and VEGF in Cancer

New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay

Open access
Wan, Zhengpeng, Floryan, Marie A., Coughlin, Mark F., Zhang, Shun, Zhong, Amy X., Shelton, Sarah E., Wang, Xun, Xu, Chenguang +2 more·2023·Advanced Healthcare Materials

Abstract

Previous studies have developed vascularized tumor spheroid models to demonstrate the impact of intravascular flow on tumor progression and treatment. However, these models have not been widely adopted so the vascularization of tumor spheroids in vitro is generally lower than vascularized tumor tissues in vivo. To improve the tumor vascularization level, a new strategy is introduced to form tumor spheroids by adding fibroblasts (FBs) sequentially to a pre‐formed tumor spheroid and demonstrate this method with tumor cell lines from kidney, lung, and ovary cancer. Tumor spheroids made with the new strategy have higher FB densities on the periphery of the tumor spheroid, which tend to enhance vascularization. The vessels close to the tumor spheroid made with this new strategy are more perfusable than the ones made with other methods. Finally, chimeric antigen receptor (CAR) T cells are perfused under continuous flow into vascularized tumor spheroids to demonstrate immunotherapy evaluation using vascularized tumor‐on‐a‐chip model. This new strategy for establishing tumor spheroids leads to increased vascularization in vitro, allowing for the examination of immune, endothelial, stromal, and tumor cell responses under static or flow conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/adhm.202201784

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several other tumor chips have been developed, encompassing features such as tumor vasculature, stromal cells, or immune cells, and offering advantages in terms of rapid fabrication, reproducibility, real-time imaging and analysis, capturing tumor type and heterogeneity, facilitating robust drug testing, target discovery and personalized therapy screenings, and enabling multicellular crosstalk.

    “Besides this model, several other tumor chips have been developed, encompassing features such as tumor vasculature (Yu et al. (2019); Wan et al. (2023); Nashimoto et al. (2020); Neufeld et al. (2021); Kim et al. (2022); Mannino et al. (2017); Shirure et al. (2018), stromal cells (Yu et al. (2019); Ibrahim et al. (2022); Karakas et al. (2017), or immune cells (Surendran et al. (2021); Aung et al. (”

    From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023

  • In ovarian cancer MPS, a microfluidic device with three parallel channels using ECs, fibroblasts, SKOV3, OV90 spheroids, and CAR T cells showed a high level of tumor vascularization and recruitment of CAR T cells.

    “| Ovarian | Wan et al. (2023) | Microfluidic device with three parallel channels | ECs, fibroblasts, SKOV3, OV90 spheroids, CAR T cells | High level of tumor vascularization and recruitment of CAR T cells |”

    From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023

  • Wan et al. developed a tumor spheroid model that allows high tumor vascularization via a living vasculature network and elucidation of the role of fibroblasts within the tumor microenvironment.

    “In an approach to improve tumor architecture, promote tumor-stromal interactions and promote tumor vascularization, Wan and colleagues developed a tumor spheroid model that allows for high levels of tumor vascularization via a living vasculature network and further allows elucidation of the role of fibroblasts within the TME (Wan et al., 2023).”

    From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023

  • The sequential spheroid result is indicative of complex microenvironmental remodeling and enhanced angiogenesis typical of in vivo vascularized tumors.

    “Interestingly, the tumor spheroids formed by the sequential approach led to the highest level of tumor vascularization, vessel perfusability and fibroblast area, which is indicative of complex microenvironmental remodeling processes and enhanced angiogenesis that typically occurs in in vivo vascularized tumors (Wan et al., 2023).”

    From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023

  • Tumor spheroids formed by sequential addition of fibroblasts to pre-formed tumor spheroids led to the highest level of tumor vascularization, vessel perfusability, and fibroblast area.

    “Interestingly, the tumor spheroids formed by the sequential approach led to the highest level of tumor vascularization, vessel perfusability and fibroblast area, which is indicative of complex microenvironmental remodeling processes and enhanced angiogenesis that typically occurs in in vivo vascularized tumors (Wan et al., 2023).”

    From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Wan et al., 2023

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 90

  1. [1]Z. Liu, Y. Wang, Y. Huang, B. Y. S. Kim, H. Shan, D. Wu, W. Jiang, Trends Pharmacol. Sci. 2019, 40, 613. 31331639 PMC7925217
  2. [2]R. Baghban, L. Roshangar, R. Jahanban‐Esfahlan, K. Seidi, A. Ebrahimi‐Kalan, M. Jaymand, S. Kolahian, T. Javaheri, P. Zare, Cell Commun. Signaling 2020, 18, 59. PMC7140346 32264958
  3. [3]A. Sontheimer‐Phelps, B. A. Hassell, D. E. Ingber, Nat. Rev. Cancer 2019, 19, 65. 30647431
  4. [4]N. D. Piccolo, V. S. Shirure, Y. Bi, S. P. Goedegebuure, S. Gholami, C. C. W. Hughes, R. C. Fields, S. C. George, Adv. Drug Delivery Rev. 2021, 175, 113798. 34015419
  5. [5]X. Liu, J. Fang, S. Huang, X. Wu, X. Xie, J. Wang, F. Liu, M. Zhang, Z. Peng, N. Hu, Microsyst. Nanoeng. 2021, 7, 50. 34567763 PMC8433302
  6. [6]M. Shang, R. H. Soon, C. T. Lim, B. L. Khoo, J. Han, Lab Chip 2019, 19, 369. 30644496
  7. [7]V. S. Shirure, C. C. W. Hughes, S. C. George, Annu. Rev. Biomed. Eng. 2021, 23, 141. 33756087
  8. [8]Y. Wu, Y. Zhou, X. Qin, Y. Liu, Biomicrofluidics 2021, 15, 061503. 34804315 PMC8589468
  9. [9]K. Haase, G. S. Offeddu, M. R. Gillrie, R. D. Kamm, Adv. Funct. Mater. 2020, 30, 2002444. 33692661 PMC7939067
  10. [10]J. Paek, S. E. Park, Q. Lu, K.‐T. Park, M. Cho, J. M. Oh, K. W. Kwon, Y.‐S. Yi, J. W. Song, H. I. Edelstein, J. Ishibashi, W. Yang, J. W. Myerson, R. Y. Kiseleva, P. Aprelev, E. D. Hood, D. Stambolian, P. Seale, V. R. Muzykantov, D. Huh, ACS Nano 2019, 13, 7627. 31194909
  11. [11]J. P. Straehla, C. Hajal, H. C. Safford, G. S. Offeddu, N. Boehnke, T. G. Dacoba, J. Wyckoff, R. D. Kamm, P. T. Hammond, Proc. Natl. Acad. Sci. U. S. A. 2022, 119, e2118697119. 35648828 PMC9191661
  12. [12]M. Campisi, S. K. Sundararaman, S. E. Shelton, E. H. Knelson, N. R. Mahadevan, R. Yoshida, T. Tani, E. Ivanova, I. Cañadas, T. Osaki, S. W. L. Lee, T. Thai, S. Han, B. P. Piel, S. Gilhooley, C. P. Paweletz, V. Chiono, R. D. Kamm, S. Kitajima, D. A. Barbie, Front. Immunol. 2020, 11, 2090. 33013881 PMC7507350
  13. [13]D. Kim, K. S. Hwang, E. U. Seo, S. Seo, B. C. Lee, N. Choi, J. Choi, H. N. Kim, Adv. Healthcare Mater. 2022, 11, 2102581. PMC11468795 35286780
  14. [14]Y. Bi, V. S. Shirure, R. Liu, C. Cunningham, L. Ding, J. M. Meacham, S. P. Goedegebuure, S. C. George, R. C. Fields, Integr. Biol. 2020, 12, 221. PMC7525664 32930334
  15. [15]J. M. Ayuso, S. Rehman, M. Virumbrales‐Munoz, P. H. Mcminn, P. Geiger, C. Fitzgerald, T. Heaster, M. C. Skala, D. J. Beebe, Sci. Adv. 2021, 7. PMC7888951 33597234
  16. [16]J. Lee, S.‐E. Kim, D. Moon, J. Doh, Lab Chip 2021, 21, 2142. 33913456
  17. [17]Y. Xiao, D. Kim, B. Dura, K. Zhang, R. Yan, H. Li, E. Han, J. Ip, P. Zou, J. Liu, A. T. Chen, A. O. Vortmeyer, J. Zhou, R. Fan, Adv. Sci. 2019, 6, 1801531. PMC6468969 31016107
  18. [18]R. Michna, M. Gadde, A. Ozkan, M. Dewitt, M. Rylander, Biotechnol. Bioeng. 2018, 115, 2793. 29940072 PMC6261298
  19. [19]A. Sobrino, D. T. T. Phan, R. Datta, X. Wang, S. J. Hachey, M. Romero‐López, E. Gratton, A. P. Lee, S. C. George, C. C. W. Hughes, Sci. Rep. 2016, 6, 31589. 27549930 PMC4994029
  20. [20]Y. Wang, R. K. Kankala, J. Zhang, L. Hao, K. Zhu, S. Wang, Y. S. Zhang, A. Chen, Adv. Sci. 2020, 7, 2002002. PMC7610277 33173735
  21. [21]P. Agarwal, H. Wang, M. Sun, J. Xu, S. Zhao, Z. Liu, K. J. Gooch, Y. Zhao, X. Lu, X. He, ACS Nano 2017, 11, 6691. 28614653 PMC5663446
  22. [22]M. Dey, B. Ayan, M. Yurieva, D. Unutmaz, I. T. Ozbolat, Adv. Biol. 2021, 5, e2100090. PMC8574137 33857356
  23. [23]F. L. L. Benjamin, X. Lu Rick, Y. Hu, H. L. Davenport, W. Dou, E. Y. Wang, N. Radulovich, M. S. Tsao, Y. Sun, M. Radisic, Adv. Funct. Mater. 2020, 30, 2000545. 33692660 PMC7939064
  24. [24]S. Park, T. Kim, S. Kim, S. You, Y. Jung, Cancers 2021, 13, 3930.34439103
  25. [25]G. Silvani, C. Basirun, H. J. Wu, C. Mehner, K. Poole, P. Bradbury, J. Chou, Adv. Ther. 2021, 4, 2100106.
  26. [26]B. A. Hassell, G. Goyal, E. Lee, A. Sontheimer‐Phelps, O. Levy, C. S. Chen, D. E. Ingber, Cell Rep. 2017, 21, 508. 29020635
  27. [27]J. Ko, J. Ahn, S. Kim, Y. Lee, J. Lee, D. Park, N. L. Jeon, Lab Chip 2019, 19, 2822. 31360969
  28. [28]S. J. Hachey, S. Movsesyan, Q. H. Nguyen, G. Burton‐Sojo, A. Tankazyan, J. Wu, T. Hoang, D. Zhao, S. Wang, M. M. Hatch, E. Celaya, S. Gomez, G. T. Chen, R. T. Davis, K. Nee, N. Pervolarakis, D. A. Lawson, K. Kessenbrock, A. P. Lee, J. Lowengrub, M. L. Waterman, C. C. W. Hughes, Lab Chip 2021, 21, 1333. 33605955 PMC8525497
  29. [29]Y. Nashimoto, R. Okada, S. Hanada, Y. Arima, K. Nishiyama, T. Miura, R. Yokokawa, Biomaterials 2020, 229, 119547. 31710953
  30. [30]Z. Hu, Y. Cao, E. A. Galan, L. Hao, H. Zhao, J. Tang, G. Sang, H. Wang, B. Xu, S. Ma, ACS Biomater. Sci. Eng. 2022, 8, 1215. 35167260
  31. [31]C. H. June, R. S. O'connor, O. U. Kawalekar, S. Ghassemi, M. C. Milone, Science 2018, 359, 1361. 29567707
  32. [32]C. H. June, M. Sadelain, N. Engl. J. Med. 2018, 379, 64. 29972754 PMC7433347
  33. [33]A. J. Hou, L. C. Chen, Y. Y. Chen, Nat. Rev. Drug Discovery 2021, 20, 531. 33972771
  34. [34]M. Martinez, E. K. Moon, Front. Immunol. 2019, 10, 128. 30804938 PMC6370640
  35. [35]R. C. Sterner, R. M. Sterner, Blood Cancer J. 2021, 11, 69. 33824268 PMC8024391
  36. [36]M. Boulch, M. Cazaux, Y. Loe‐Mie, R. Thibaut, B. Corre, F. Lemaître, C. L. Grandjean, Z. Garcia, P. Bousso, Sci. Immunol. 2021, 6. 33771887
  37. [37]A. Rodriguez‐Garcia, A. Palazon, E. Noguera‐Ortega, D. J. Powell, S. Guedan, Front. Immunol. 2020, 11, 1109. 32625204 PMC7311654
  38. [38]K. Paterson, S. Paterson, T. Mulholland, S. B. Coffelt, M. Zagnoni, IEEE Open J. Eng. Med. Biol. 2022, 3, 86. 35813488 PMC9252335
  39. [39]F. Jacob, R. D. Salinas, D. Y. Zhang, P. T. T. Nguyen, J. G. Schnoll, S. Z. H. Wong, R. Thokala, S. Sheikh, D. Saxena, S. Prokop, D.‐A. Liu, X. Qian, D. Petrov, T. Lucas, H. I. Chen, J. F. Dorsey, K. M. Christian, Z. A. Binder, M. Nasrallah, S. Brem, D. M. O'rourke, G.‐L. Ming, H. Song, Cell 2020, 180, 188. 31883794 PMC7556703
  40. [40]J. Michie, P. A. Beavis, A. J. Freeman, S. J. Vervoort, K. M. Ramsbottom, V. Narasimhan, E. J. Lelliott, N. Lalaoui, R. G. Ramsay, R. W. Johnstone, J. Silke, P. K. Darcy, I. Voskoboinik, C. J. Kearney, J. Oliaro, Cancer Immunol. Res. 2019, 7, 183. 30651288
  41. [41]Y. Ando, E. L. Siegler, H. P. Ta, G. E. Cinay, H. Zhou, K. A. Gorrell, H. Au, B. M. Jarvis, P. Wang, K. Shen, Adv. Healthcare Mater. 2019, 8, e1900001. PMC6448565 30734529
  42. [42]J. Pan, J. Mestas, M. D. Burdick, R. J. Phillips, G. V. Thomas, K. Reckamp, J. A. Belperio, R. M. Strieter, Mol. Cancer 2006, 5, 56. 17083723 PMC1636662
  43. [43]D. Huang, Y. Ding, M. Zhou, B. I. Rini, D. Petillo, C.‐N. Qian, R. Kahnoski, P. A. Futreal, K. A. Furge, B. T. Teh, Cancer Res. 2010, 70, 1063. 20103651 PMC3719378
  44. [44]A. Amann, M. Zwierzina, S. Koeck, G. Gamerith, E. Pechriggl, J. M. Huber, E. Lorenz, J. M. Kelm, W. Hilbe, H. Zwierzina, J. Kern, Sci. Rep. 2017, 7, 2963. 28592821 PMC5462801
  45. [45]I. Cañadas, F. Rojo, Á. Taus, O. Arpí, M. Arumí‐Uría, L. Pijuan, S. Menéndez, S. Zazo, M. Dómine, M. Salido, S. Mojal, A. G. De Herreros, A. Rovira, J. Albanell, E. Arriola, Clin. Cancer Res. 2014, 20, 938. 24284055
  46. [46]Y. Zhang, C. K. Elechalawar, W. Yang, A. N. Frickenstein, S. Asfa, K.‐M. Fung, B. N. Murphy, S. K. Dwivedi, G. Rao, A. Dey, Mater. Today 2022, 56, 1369. PMC9523457 36188120
  47. [47]Z. Zhang, D. Jiang, H. Yang, Z. He, X. Liu, W. Qin, L. Li, C. Wang, Y. Li, H. Li, H. Xu, H. Jin, Q. Qian, Cell Death Dis. 2019, 10, 476. 31209210 PMC6572851
  48. [48]A. Morello, M. Sadelain, P. S. Adusumilli, Cancer Discov 2016, 6, 133. 26503962 PMC4744527
  49. [49]M. Shao, S. Hollar, D. Chambliss, J. Schmitt, R. Emerson, B. Chelladurai, S. Perkins, M. Ivan, D. Matei, Mol. Cancer Ther. 2012, 11, 1576. 22700681 PMC4497519
  50. [50]A. Agarwal, L. Covic, L. M. Sevigny, N. C. Kaneider, K. Lazarides, G. Azabdaftari, S. Sharifi, A. Kuliopulos, Mol. Cancer Ther. 2008, 7, 2746. 18790755 PMC2735132
  51. [51]G. S. Offeddu, J. C. Serrano, S. W. Chen, S. E. Shelton, Y. Shin, M. Floryan, R. D. Kamm, J. Biomech. 2021, 119, 110330. 33631662 PMC8314430
  52. [52]A. C. Newman, M. N. Nakatsu, W. Chou, P. D. Gershon, C. C. W. Hughes, Mol. Biol. Cell 2011, 22, 3791. 21865599 PMC3192859
  53. [53]M. Murakami, M. Simons, Curr. Opin. Hematol. 2008, 15, 215. 18391788 PMC2745288
  54. [54]P. Nowak‐Sliwinska, K. Alitalo, E. Allen, A. Anisimov, A. C. Aplin, R. Auerbach, H. G. Augustin, D. O. Bates, J. R. Van Beijnum, R. H. F. Bender, G. Bergers, A. Bikfalvi, J. Bischoff, B. C. Böck, P. C. Brooks, F. Bussolino, B. Cakir, P. Carmeliet, D. Castranova, A. M. Cimpean, O. Cleaver, G. Coukos, G. E. Davis, M. De Palma, A. Dimberg, R. P. M. Dings, V. Djonov, A. C. Dudley, N. P. Dufton, S.‐M. Fendt, et al., Angiogenesis 2018, 21, 425.29766399
  55. [55]Y.‐S. Torisawa, B. Mosadegh, G. D. Luker, M. Morell, K. S. O'shea, S. Takayama, Integr. Biol. 2009, 1, 649. PMC2825702 20027373
  56. [56]M. Krieg, Y. Arboleda‐Estudillo, P.‐H. Puech, J. Käfer, F. Graner, D. J. Müller, C.‐P. Heisenberg, Nat. Cell Biol. 2008, 10, 429. 18364700
  57. [57]R. A. Foty, M. S. Steinberg, Dev. Biol. 2005, 278, 255. 15649477
  58. [58]N. Sivakumar, H. V. Warner, S. M. Peirce, M. J. Lazzara, bioRxiv 2021, 10.1101/2021.08.05.455232. · DOI
  59. [59]F. Van Roy, G. Berx, Cell. Mol. Life Sci. 2008, 65, 3756. 18726070 PMC11131785
  60. [60]P. Murray, G. Frampton, P. Nelson, BMJ 1999, 319, 332. 10435939 PMC1126974
  61. [61]A. Labernadie, T. Kato, A. Brugués, X. Serra‐Picamal, S. Derzsi, E. Arwert, A. Weston, V. González‐Tarragó, A. Elosegui‐Artola, L. Albertazzi, J. Alcaraz, P. Roca‐Cusachs, E. Sahai, X. Trepat, Nat. Cell Biol. 2017, 19, 224. 28218910 PMC5831988
  62. [62]M. Janiszewska, M. C. Primi, T. Izard, J. Biol. Chem. 2020, 295, 2495. 31937589 PMC7039572
  63. [63]P. Salmenperä, E. Kankuri, J. Bizik, V. Sirén, I. Virtanen, S. Takahashi, M. Leiss, R. Fässler, A. Vaheri, Exp. Cell Res. 2008, 314, 3444. 18824166
  64. [64]B. M. Gumbiner, Nat. Rev. Mol. Cell Biol. 2005, 6, 622. 16025097
  65. [65]T. J. C. Harris, U. Tepass, Nat. Rev. Mol. Cell Biol. 2010, 11, 502. 20571587
  66. [66]E. Sahai, I. Astsaturov, E. Cukierman, D. G. Denardo, M. Egeblad, R. M. Evans, D. Fearon, F. R. Greten, S. R. Hingorani, T. Hunter, R. O. Hynes, R. K. Jain, T. Janowitz, C. Jorgensen, A. C. Kimmelman, M. G. Kolonin, R. G. Maki, R. S. Powers, E. Puré, D. C. Ramirez, R. Scherz‐Shouval, M. H. Sherman, S. Stewart, T. D. Tlsty, D. A. Tuveson, F. M. Watt, V. Weaver, A. T. Weeraratna, Z. Werb, Nat. Rev. Cancer 2020, 20, 174. 31980749 PMC7046529
  67. [67]P. J. Kowalski, M. A. Rubin, C. G. Kleer, Breast Cancer Res. 2003, 5, R217. 14580257 PMC314411
  68. [68]A. Kumar, A. T. Khani, A. S. Ortiz, S. Swaminathan, Front. Immunol. 2022, 13, 901277. 35865534 PMC9294178
  69. [69]N. Frey, D. Porter, Biol. Blood Marrow Transplant. 2019, 25, e123. 30586620
  70. [70]R. M. Sterner, R. Sakemura, M. J. Cox, N. Yang, R. H. Khadka, C. L. Forsman, M. J. Hansen, F. Jin, K. Ayasoufi, M. Hefazi, K. J. Schick, D. K. Walters, O. Ahmed, D. Chappell, T. Sahmoud, C. Durrant, W. K. Nevala, M. M. Patnaik, L. R. Pease, K. E. Hedin, N. E. Kay, A. J. Johnson, S. S. Kenderian, Blood 2019, 133, 697. 30463995 PMC6376281
  71. [71]L. Xue, Y. Yi, Q. Xu, L. Wang, X. Yang, Y. Zhang, X. Hua, X. Chai, J. Yang, Y. Chen, G. Tao, B. Hu, X. Wang, Cell Discov. 2021, 7, 84. 34518515 PMC8437938
  72. [72]L. Kang, X. Tang, J. Zhang, M. Li, N. Xu, W. Qi, J. Tan, X. Lou, Z. Yu, J. Sun, Z. Wang, H. Dai, J. Chen, G. Lin, D. Wu, L. Yu, Exp. Hematol. Oncol. 2020, 9, 11. 32523801 PMC7278071
  73. [73]S. R. Bailey, S. Vatsa, R. C. Larson, A. A. Bouffard, I. Scarfò, M. C. Kann, T. R. Berger, M. B. Leick, M. Wehrli, A. Schmidts, H. Silva, K. A. Lindell, A. Demato, K. M. E. Gallagher, M. J. Frigault, M. V. Maus, Blood Cancer Discovery 2022, 3, 136. 35015685 PMC9414118
  74. [74]J. Wei, Y. Liu, C. Wang, Y. Zhang, C. Tong, G. Dai, W. Wang, J. E. J. Rasko, J. J. Melenhorst, W. Qian, A. Liang, W. Han, Signal Transduction Targeted Ther. 2020, 5, 134. PMC7388484 32728035
  75. [75]Z. Wan, A. X. Zhong, S. Zhang, G. Pavlou, M. F. Coughlin, S. E. Shelton, H. T. Nguyen, J. H. Lorch, D. A. Barbie, R. D. Kamm, Small Methods 2022, 6, e2200143. 35373502 PMC9844969
  76. [76]E. A. Margolis, D. S. Cleveland, Y. P. Kong, J. A. Beamish, W. Y. Wang, B. M. Baker, A. J. Putnam, Lab Chip 2021, 21, 1150. 33538719 PMC7990720
  77. [77]N. Kosyakova, D. D. Kao, M. Figetakis, F. López‐Giráldez, S. Spindler, M. Graham, K. J. James, J. Won Shin, X. Liu, G. T. Tietjen, J. S. Pober, W. G. Chang, npj Regener. Med. 2020, 5, 1. PMC6944695 31934351
  78. [78]M. L. Moya, Y.‐H. Hsu, A. P. Lee, C. C. W. Hughes, S. C. George, Tissue Eng., Part C 2013, 19, 730. PMC3719485 23320912
  79. [79]X. Wang, D. T. T. Phan, A. Sobrino, S. C. George, C. C. W. Hughes, A. P. Lee, Lab Chip 2016, 16, 282. 26616908 PMC4869859
  80. [80]S. Bang, S.‐R. Lee, J. Ko, K. Son, D. Tahk, J. Ahn, C. Im, N. L. Jeon, Sci. Rep. 2017, 7, 8083. 28808270 PMC5556097
  81. [81]S. Zhang, Z. Wan, G. Pavlou, A. X. Zhong, L. Xu, R. D. Kamm, Adv. Funct. Mater. 2022, 32, 2206767. 36569597 PMC9783342
  82. [82]A. Mykuliak, A. Yrjänäinen, A.‐J. Mäki, A. Gebraad, E. Lampela, M. Kääriäinen, T.‐K. Pakarinen, P. Kallio, S. Miettinen, H. Vuorenpää, Front. Bioeng. Biotechnol. 2022, 10, 764237. 35211462 PMC8861308
  83. [83]S. Kim, H. Lee, M. Chung, N. L. Jeon, Lab Chip 2013, 13, 1489. 23440068
  84. [84]K. Sugihara, Y. Yamaguchi, S. Usui, Y. Nashimoto, S. Hanada, E. Kiyokawa, A. Uemura, R. Yokokawa, K. Nishiyama, T. Miura, PLoS One 2020, 15, e0240552. 33112918 PMC7592787
  85. [85]Y. K. Park, T.‐Y. Tu, S. H. Lim, I. J. M. Clement, S. Y. Yang, R. D. Kamm, Cell Mol. Bioeng. 2014, 7, 15. 24660039 PMC3960002
  86. [86]M. P. Cuchiara, D. J. Gould, M. K. Mchale, M. E. Dickinson, J. L. West, Adv. Funct. Mater. 2012, 22, 4511. 23536744 PMC3607213
  87. [87]A. Brown, H. He, E. Trumper, J. Valdez, P. Hammond, L. G. Griffith, Biomaterials 2020, 243, 119921. 32172030 PMC7203641
  88. [88]Z. Wan, S. Zhang, A. X. Zhong, S. E. Shelton, M. Campisi, S. K. Sundararaman, G. S. Offeddu, E. Ko, L. Ibrahim, M. F. Coughlin, T. Liu, J. Bai, D. A. Barbie, R. D. Kamm, Biomaterials 2021, 276, 121032. 34303155 PMC9891349
  89. [89]G. E. Davis, D. R. Senger, Circ. Res. 2005, 97, 1093. 16306453
  90. [90]G. C. Sephel, J. M. Davidson, J. Invest. Dermatol. 1986, 86, 279. 3745952

Cited by

Sorted by citations

Authors
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D.
Affiliations
  • Dana-Farber Cancer Institute (US)
  • Massachusetts Institute of Technology (US)
  • Southern Medical University (CN)
Corresponding author
  • Xu, Chenguang
  • Barbie, David A.
  • Kamm, Roger D.
Venue
Advanced Healthcare Materials
Publisher
Wiley
Published
2022-11-15
Volume
12
Issue
14
Pages
e2201784-e2201784
ISSN
  • 2192-2640 (ISSN-L)
  • 2192-2659
OpenAlex
W4308220489
Cited by
84
References
15
Citations by year
2026: 20 · 2025: 23 · 2024: 32 · 2023: 8 · 2022: 1
FWCI
4.65
Type
journal article
Language
en
Open access
Locations
  • Advanced Healthcare Materials (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
Funders
  • National Natural Science Foundation of China (81903158, 32170940)
  • Natural Science Foundation of Guangdong Province (2022A1515012658)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
tumor spheroids, tumor vascularization, fibroblast density, immunotherapy evaluation, kidney cancer, lung cancer, ovarian cancer, tumor microenvironment
MeSH terms
Humans, Neovascularization, Pathologic, Spheroids, Cellular, Microfluidics, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review